Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $360000.0.

  • AtriCure's Change in Account Payables fell 9152.74% to $360000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 18701.55%. This contributed to the annual value of -$1.5 million for FY2024, which is 12478.55% down from last year.
  • Latest data reveals that AtriCure reported Change in Account Payables of $360000.0 as of Q3 2025, which was down 9152.74% from $677000.0 recorded in Q2 2025.
  • In the past 5 years, AtriCure's Change in Account Payables registered a high of $4.2 million during Q3 2024, and its lowest value of -$5.8 million during Q4 2024.
  • For the 5-year period, AtriCure's Change in Account Payables averaged around $649894.7, with its median value being $956000.0 (2021).
  • Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 173825.14% in 2022, then skyrocketed by 25349.42% in 2024.
  • Over the past 5 years, AtriCure's Change in Account Payables (Quarter) stood at $183000.0 in 2021, then crashed by 1738.25% to -$3.0 million in 2022, then skyrocketed by 167.71% to $2.0 million in 2023, then tumbled by 384.24% to -$5.8 million in 2024, then skyrocketed by 106.24% to $360000.0 in 2025.
  • Its Change in Account Payables stands at $360000.0 for Q3 2025, versus $677000.0 for Q2 2025 and -$722000.0 for Q1 2025.